iShares U.S. Pharmaceuticals ETF (IHE)

iShares U.S. Pharmaceuticals ETF (IHE $86.68)
- $86.68 P/E (TTM): 21.49X Cap: $975M
- View IHE Profile
- View Questions on IHE

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

iShares U.S. Pharmaceuticals ETF (IHE $86.68)
- $86.68 P/E (TTM): 21.49X Cap: $975M
- View IHE Profile
- View Questions on IHE
VANECK ETF TR (PPH $106.81)
- $106.81 P/E (TTM): 12.46X Cap: $1.19B
- View PPH Profile
- View Questions on PPH

Q: What are your thoughts on PPH (VanEck Pharmaceutical ETF? Symbol not found when trying to look up this ETF?

Read Answer Asked on January 06, 2026

Gilead Sciences Inc. (GILD $141.95)
- $141.95 P/E (TTM): 21.6X Cap: $176.11B
- View GILD Profile
- View Questions on GILD
Intuitive Surgical Inc. (ISRG $504.22)
- $504.22 P/E (TTM): 67.05X Cap: $178.74B
- View ISRG Profile
- View Questions on ISRG
AbbVie Inc. (ABBV $223.01)
- $223.01 P/E (TTM): 168.27X Cap: $394.14B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $227.25)
- $227.25 P/E (TTM): 21.94X Cap: $547.51B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $1,037.15)
- $1,037.15 P/E (TTM): 50.1X Cap: $980.50B
- View LLY Profile
- View Questions on LLY
Medtronic plc. (MDT $102.96)
- $102.96 P/E (TTM): 27.3X Cap: $131.99B
- View MDT Profile
- View Questions on MDT
Stryker Corporation (SYK $369.56)
- $369.56 P/E (TTM): 46.56X Cap: $141.32B
- View SYK Profile
- View Questions on SYK
Thermo Fisher Scientific Inc (TMO $578.61)
- $578.61 P/E (TTM): 34.21X Cap: $217.38B
- View TMO Profile
- View Questions on TMO
State Street Health Care Select Sector SPDR ETF (XLV $154.74)
- $154.74 P/E (TTM): 23.97X Cap: $41.12B
- View XLV Profile
- View Questions on XLV
iShares U.S. Medical Devices ETF (IHI $60.08)
- $60.08 P/E (TTM): 30.04X Cap: $3.87B
- View IHI Profile
- View Questions on IHI
Sabra Health Care REIT Inc. (SBRA $18.73)
- $18.73 P/E (TTM): 25.37X Cap: $4.67B
- View SBRA Profile
- View Questions on SBRA
Healthcare Realty Trust Incorporated (HR $16.79)
- $16.79 Cap: $5.90B
- View HR Profile
- View Questions on HR
iShares U.S. Pharmaceuticals ETF (IHE $86.68)
- $86.68 P/E (TTM): 21.49X Cap: $975M
- View IHE Profile
- View Questions on IHE
Catalyst Pharmaceuticals Inc. (CPRX $24.30)
- $24.30 P/E (TTM): 14.29X Cap: $2.98B
- View CPRX Profile
- View Questions on CPRX

Q: There was an article in the Globe and Mail today by David Rosenberg about the aging population and he suggested health care related investments such as health care REITS, pharma, devices, and services. What do you think of this idea and can you give me a few recommendations in canada and the US for each of the 4 categories (health reits, pharma, devices, sefrvices)? A mix of ETFS and individual stocks would be great.

Read Answer Asked by Carla on July 08, 2025

Regeneron Pharmaceuticals Inc. (REGN $741.45)
- $741.45 P/E (TTM): 17.92X Cap: $77.92B
- View REGN Profile
- View Questions on REGN
Johnson & Johnson (JNJ $227.25)
- $227.25 P/E (TTM): 21.94X Cap: $547.51B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $1,037.15)
- $1,037.15 P/E (TTM): 50.1X Cap: $980.50B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $110.27)
- $110.27 P/E (TTM): 14.32X Cap: $273.69B
- View MRK Profile
- View Questions on MRK
Pfizer Inc. (PFE $26.44)
- $26.44 P/E (TTM): 15.17X Cap: $150.33B
- View PFE Profile
- View Questions on PFE
Thermo Fisher Scientific Inc (TMO $578.61)
- $578.61 P/E (TTM): 34.21X Cap: $217.38B
- View TMO Profile
- View Questions on TMO
Novo Nordisk A/S (NVO $59.43)
- $59.43 P/E (TTM): 16.86X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
iShares Biotechnology ETF (IBB $172.43)
- $172.43 P/E (TTM): 20.63X Cap: $8.51B
- View IBB Profile
- View Questions on IBB
Moderna Inc. (MRNA $44.07)
- $44.07 Cap: $17.21B
- View MRNA Profile
- View Questions on MRNA
VANECK ETF TR (BBH $196.65)
- $196.65 P/E (TTM): 20.86X Cap: $390M
- View BBH Profile
- View Questions on BBH
iShares U.S. Pharmaceuticals ETF (IHE $86.68)
- $86.68 P/E (TTM): 21.49X Cap: $975M
- View IHE Profile
- View Questions on IHE

Q: I'm looking for names in the large cap pharma and biotech sectors. Can you suggest two stocks for each sector that look attractive to you right now for a 5+ year horizon? Thanks.

Read Answer Asked by Stefan on March 10, 2023